The creation of Telos95 took several years of research and development, including clinical research (in vitro) by Life Length´s TAT technology of Spain, and now the latest human clinical study conducted by Princeton Consumer Research.
The DNA test used in the study was “Cawthon qPCR Assay,” which tested the effectiveness of Telos95.
Telomeres hold information about the path of subjects’ health and may provide the single most important biomarker of aging. TeloYear age is a DNA test that determines cellular age. Telomere length determines one’s age in TeloYear, which maybe older or younger than one’s actual age.
Telomere lengths can indicate the age of cells and tend to shorten and fray with age. How fast they shorten and eventually become cell senescence (a stage where cells deteriorate- nonfunctional) depends on genes, environment, stress level, diet, and lifestyle.
Telos95 is formulated with very powerful antioxidant polyphenols, according to CN. The company suggested the ingredient can help decreases the time it takes to shorten telomere cellular age.
The year-long human clinical trial included 50 subjects. Over the course of six months 25 subjects in group A were instructed to take one 95mg capsule daily, while group B took two capsules once daily.
Results found group A decreased in their TeloYear age on average by 7.43 years, and group B decreased their TeloYear age by 8.52 years.
This is exciting news for CN, according to Ahmad Alkayali, CEO of CN and the inventor Telos95. He commented, “This is the longevity breakthrough supplement of the century. The human study is the first of its kind to confirm efficacy on telomere health and we are not aware of any other human study on natural supplements that exists. CN is planning to market this unique supplement worldwide.”